9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Market cap: $6.6M (12/23/2025)
Price: $0.19
Other Events
Theriva Biologics Files Prospectus Supplement for $2.89M Common Stock Sale
Theriva Biologics, Inc. Files Prospectus Supplement for $4.02M Stock Sale
VIRAGE trial on Nab-Paclitaxel & Gemcitabine for mPDAC
Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
VIRAGE trial: randomized Phase IIb, open-label, study of Nab-Paclitaxel and Gemcitabine with/without intravenous VCN-01 in Patients with Metastatic Pancreatic Cancer (mPDAC)
Investor Presentation
Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload